Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term Multiple human targets is a non-specific designation used in pharmacological databases and clinical research to describe drugs or assays that involve more than one distinct biological molecule. It does not refer to a single protein, enzyme, or receptor, but rather serves as a placeholder when a drug's activity is distributed across various human proteins or when specific targets have not been individually itemized. Because it lacks a unique biological identity, it cannot be classified by a single molecular family or biological function. In drug development, this label often applies to polypharmacological agents, such as multi-kinase inhibitors, that interact with a diverse set of receptors or enzymes to achieve a therapeutic effect. Consequently, it is considered an incorrect or insufficient entry for specific target identification in a structured biochemical context.
Not applicable as this is a generic placeholder for multiple distinct biological entities.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple human targets.